New York, NY--Verywell Mind announced in a news release a new survey, titled Psychedelics & Mental Health, examining Americans' awareness and opinions of psychedelics used in mental health treatment.
[Image via Verywell]
The survey, per the release, was conducted as research from the past year suggests options such as Ketamine and Psilocybin show promising results in treating various conditions, including addiction, depression, and PTSD. Additionally, the growing influx of psychedelic-assisted therapy, such as online ketamine-therapy providers, has made new treatments more available.
The Psychedelics & Mental Health survey shows awareness and acceptance of psychedelic therapy overall was greater among those currently in therapy, but others are catching on. Thirty-six percent of Americans who have seen a therapist in the last 30 days feel positive about psychedelics being used as part of a treatment for mental health (compared to 24% overall), and 34% would be willing to try psychedelics as part of treatment for a mental health condition (compared to 17% overall).
Concerning access, 45% of those surveyed say they'd support the legalization of at least some psychedelics for the treatment of a mental health condition under the supervision of a professional, and they'd be more likely to consider taking psychedelics if they were recommended by a doctor or therapist (35%), or if the specific drug were FDA-approved (30%).
Learn more about the survey in the entire release.